Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US FDA Progress Report Highlights Biomarkers, Continuous Manufacturing, Antibiotic Testing

Mar 31 2017

• By Brenda Sandburg

FDASignBldg21Entrance_1200x675

Related Content

Keeping Track: Clovis Completes NDA; FDA Clears 3D-Printed Antiepileptic But Declines Preservative-Free Eye Drug

Aug 10 2015

FDA Tries to Clear Up Continuous Manufacturing Ambiguities

Mar 27 2015

FDA Science Board's Report: Legislative Negotiating Tactic, Or Just Whining For Money?

Sep 28 2015

Sarepta's Eteplirsen Approved After Contentious Internal FDA Debate

Sep 20 2016

FDA Funding Debate Reframed By GAO Reports On Strategic Planning

Jun 16 2016

FDA Ushers In Era of New Drug Manufacturing Technologies

Jun 20 2016

Related Companies

Sarepta Therapeutics, Inc.

Aprecia Pharmaceuticals

Vertex Pharmaceuticals Incorporated

Additional Topics

Regulation FDA Clinical Trials Manufacturing BioPharmaceutical

More from US FDA

More from Agency Leadership

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window